Intracavitary thiotepa in malignant pleural and peritoneal effusions.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy; D002648:Child; D005122:Exudates and Transudates / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D007267:Injections; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010529:Peritoneal Cavity / Q000503:physiopathology*; D010996:Pleural Effusion / Q000188:drug therapy*; D011677:Punctures; D013852:Thiotepa / Q000627:therapeutic use*; D014565:Urogenital Neoplasms / Q000188:drug therapy
D013852:Thiotepa